Patent · US Active

Oligomeric compounds comprising 4′-thionucleosides for use in gene modulation

US7939677B2 · kind B2 · utility

93Cited by
199References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 31, 2010
Grant dateMay 10, 2011
Priority date
Expiry dateAug 31, 2030

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02P20/55
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention provides modified oligomeric compounds and compositions of oligomeric compounds for use in the RNA interference pathway of gene modulation. The modified oligomeric compounds include siRNA and asRNA having at least one affinity modification.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.